ILMN Share Price

Open 168.94 Change Price %
High 171.98 1 Day 2.89 1.72
Low 167.82 1 Week 7.09 4.34
Close 170.58 1 Month 3.76 2.25
Volume 874067 1 Year 15.24 9.81
52 Week High 186.88
52 Week Low 119.37
ILMN Important Levels
Resistance 2 174.44
Resistance 1 172.85
Pivot 170.13
Support 1 168.31
Support 2 166.72
NASDAQ USA Most Active Stocks
MU 28.43 7.40%
MU 28.43 7.40%
MU 28.43 7.40%
FNFG 10.18 -0.20%
FTR 2.09 7.73%
FTR 2.09 7.73%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
PGRX 0.06 200.00%
AMCF 0.10 100.00%
VALV 0.04 100.00%
LOCM 0.09 50.00%
BGMD 0.08 33.33%
ESMC 0.12 33.33%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Illumina, Inc. (NASDAQ: ILMN)

ILMN Technical Analysis 4
As on 24th Mar 2017 ILMN Share Price closed @ 170.58 and we RECOMMEND Buy for LONG-TERM with Stoploss of 151.57 & Strong Buy for SHORT-TERM with Stoploss of 162.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
ILMN Target for March
1st Target up-side 174
2nd Target up-side 178.63
3rd Target up-side 183.25
1st Target down-side 160.8
2nd Target down-side 156.17
3rd Target down-side 151.55
ILMN Other Details
Segment EQ
Market Capital 5882942464.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.illumina.com
ILMN Address
ILMN
5200 Illumina Way
San Diego, CA 92122
United States
Phone: 858-202-4500
Fax: 858-202-4766
ILMN Latest News
Interactive Technical Analysis Chart Illumina, Inc. ( ILMN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Illumina, Inc.
ILMN Business Profile
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. In February 2014, Illumina, Inc. announced that Novogene purchased one HiSeq X Ten.